undefined
EUTM file information

019061503

BICYCLE


July 29, 2024

Trademark Summary

The trademark application BICYCLE was filed by Bicycletx Limited, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). The application was published for oppositions on September 18, 2024, and still open for oppositions.

The application was filed in English (French was selected as the second language).


Goods And Services

  • The mark was filed in class 5 with following description of goods:
    1. Pharmaceuticals
    2. Pharmaceutical preparations
    3. Pharmaceutical products
    4. Pharmaceutical products and preparations for use in relation to oncology
    5. Pharmaceutical products and preparations for use in relation to ophthalmology
    6. Pharmaceutical products and preparations for use in relation to neurology
    7. Anti-infective pharmaceutical products and preparations
    8. Pharmaceutical products and preparations for the treatment and/or prevention of respiratory disease
    9. Pharmaceutical products and preparations for the treatment and/or prevention of cardiovascular disease
    10. Pharmaceutical products and preparations for the treatment and/or prevention of metabolic disease
    11. Pharmaceutical products and preparations for the treatment and/or prevention of viral infections
    12. Pharmaceutical products and preparations for use in diagnostics and imaging
    13. Pharmaceutical products and preparations for the treatment and/or prevention of renal disease
    14. Pharmaceutical products and preparations for the treatment and/or prevention of gastrointestinal disease
    15. Pharmaceutical products and preparations for the treatment and/or prevention of muscular skeletal disease.
  • The mark was filed in class 42 with following description of goods:
    1. Scientific and technological services and research and design relating thereto
    2. Industrial analysis and research services
    3. Pharmaceutical research and development services
    4. Medical research and development services
    5. Pharmaceutical testing and clinical trials
    6. Clinical trials
    7. Research and development in the field of oncology
    8. Research and development in the field of ophthalmology
    9. Research and development in the field of neurology
    10. Research and development in the field of anti-infective pharmaceuticals
    11. Research and development in the field of respiratory disease
    12. Research and development in the field of cardiovascular disease
    13. Research and development in the field of metabolic disease
    14. Research and development in the field of antiviral drugs
    15. Research and development in the field of diagnostics and imaging
    16. Research and development in the field of renal disease
    17. Research and development in the field of gastrointestinal disease
    18. Research and development in the field of muscular skeletal disease
    19. Information consultancy and advisory services relating to the aforesaid.
  • The mark was filed in class 44 with following description of goods:
    1. Medical services
    2. Healthcare services
    3. Pharmaceutical services
    4. Medical consulting services
    5. Advisory services relating to pharmaceuticals
    6. Consultancy and information services relating to pharmaceuticals
    7. Medical services in the field of oncology
    8. Medical services in the field of ophthalmology
    9. Medical services in the field of neurology
    10. Medical services in the field of anti-infectives
    11. Medical services in connection with respiratory disease
    12. Medical services in connection with cardiovascular disease
    13. Medical services in connection with metabolic disease
    14. Medical services in connection with the treatment and/or prevention of viral infections
    15. Medical services in connection with diagnostics and imaging
    16. Medical services in connection with renal disease
    17. Medical services in connection with gastrointestinal disease
    18. Medical services in connection with muscular skeletal disease
    19. Pharmaceutical services in the field of oncology
    20. Pharmaceutical services in the field of ophthalmology
    21. Pharmaceutical services in the field of neurology
    22. Pharmaceutical services in the field of anti-infectives
    23. Pharmaceutical services in connection with respiratory disease
    24. Pharmaceutical services in connection with cardiovascular disease
    25. Pharmaceutical services in connection with metabolic disease
    26. Pharmaceutical services in connection with the treatment and/or prevention of viral infections
    27. Pharmaceutical services in connection with diagnostics and imaging
    28. Pharmaceutical services in connection with renal disease
    29. Pharmaceutical services in connection with gastrointestinal disease
    30. Pharmaceutical services in connection with muscular skeletal disease
    31. Information, consultancy and advisory services relating to the aforesaid.